Vaxart, Inc.: Form 10-K for the period ended Jun 30, 2013
Filed with the SEC on Sep 27, 2013 and accepted by EDGAR at Sep 27, 2013, 15:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2012-07-01 to 2013-06-30 | $33.6m | us-gaap:Revenues |
| Cost of revenue | 12 months2012-07-01 to 2013-06-30 | $20.4m | us-gaap:CostOfServices |
| Research and development | 12 months2012-07-01 to 2013-06-30 | $19.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2012-07-01 to 2013-06-30 | −$22.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2012-07-01 to 2013-06-30 | $100.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2012-07-01 to 2013-06-30 | −$8.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2012-07-01 to 2013-06-30 | −$0.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2012-07-01 to 2013-06-30 | −$0.31 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2012-07-01 to 2013-06-30 | 28,217,515 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2012-07-01 to 2013-06-30 | −$13.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2012-07-01 to 2013-06-30 | $1.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-06-30 | $66.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-06-30 | $80.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $84.3m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $15.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-06-30 | $16.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-06-30 | $68.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-13-012393. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.